Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Peking Union Medical College Hospital
Vanderbilt-Ingram Cancer Center
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)